THE 2-MINUTE RULE FOR MLN8054

 one prior program of chemotherapy for advanced breast cancer and throughout the full trial, earlier publicity to any FGFR inhibitor, major medical procedures or radiotherapy inside four months ahead of first dose of research procedure and having strong inhibitors or inducers of CYP3A4 or CYP2D6. Any of the following cardiac criteria precluded su